SE8001339L - Antihyperkolesteraemiskt medel, monakolin k och framstellning derav - Google Patents

Antihyperkolesteraemiskt medel, monakolin k och framstellning derav

Info

Publication number
SE8001339L
SE8001339L SE8001339A SE8001339A SE8001339L SE 8001339 L SE8001339 L SE 8001339L SE 8001339 A SE8001339 A SE 8001339A SE 8001339 A SE8001339 A SE 8001339A SE 8001339 L SE8001339 L SE 8001339L
Authority
SE
Sweden
Prior art keywords
antihypercolesteremic
monacoline
medicine
preparation
monascus
Prior art date
Application number
SE8001339A
Other languages
English (en)
Other versions
SE453301B (sv
Inventor
A Endo
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of SE8001339L publication Critical patent/SE8001339L/sv
Publication of SE453301B publication Critical patent/SE453301B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Obesity (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SE8001339A 1979-02-20 1980-02-20 Antihyperkolesterolemiskt medel, monakolin k, forfarande for framstellning derav samt farmaceutisk komposition innehallande detsamma SE453301B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP54017856A JPS5925599B2 (ja) 1979-02-20 1979-02-20 新生理活性物質モナコリンｋおよびその製造法

Publications (2)

Publication Number Publication Date
SE8001339L true SE8001339L (sv) 1980-08-21
SE453301B SE453301B (sv) 1988-01-25

Family

ID=11955290

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8001339A SE453301B (sv) 1979-02-20 1980-02-20 Antihyperkolesterolemiskt medel, monakolin k, forfarande for framstellning derav samt farmaceutisk komposition innehallande detsamma

Country Status (27)

Country Link
JP (1) JPS5925599B2 (sv)
KR (1) KR830002801B1 (sv)
AT (1) AT373915B (sv)
AU (1) AU532626B2 (sv)
BE (1) BE881825A (sv)
CA (1) CA1129794A (sv)
CH (1) CH645890A5 (sv)
DD (1) DD154494A5 (sv)
DE (2) DE3051175C2 (sv)
DK (2) DK149095C (sv)
ES (1) ES488796A0 (sv)
FI (1) FI66427C (sv)
FR (1) FR2449685B1 (sv)
GB (1) GB2046737B (sv)
HU (1) HU182069B (sv)
IE (1) IE49743B1 (sv)
IT (1) IT1175260B (sv)
MX (1) MX6314E (sv)
NL (1) NL191540C (sv)
NO (1) NO153974C (sv)
NZ (1) NZ192919A (sv)
PH (1) PH15145A (sv)
PL (1) PL124304B1 (sv)
SE (1) SE453301B (sv)
SG (1) SG6784G (sv)
SU (2) SU1158048A3 (sv)
ZA (1) ZA80962B (sv)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55150898A (en) * 1979-05-11 1980-11-25 Sankyo Co Ltd Preparation of a new physiologically active substance mb-530b
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
JPS5621594A (en) * 1979-07-27 1981-02-28 Sankyo Co Ltd Mb-530b carboxylic acid metal salt and its preparation
PT72394B (en) * 1980-02-04 1982-09-06 Merck & Co Inc Process for preparing dihydro and tetrahydromevinoline hypocholesterolimics
AU548996B2 (en) * 1980-02-04 1986-01-09 Merck & Co., Inc. Tetrahydro-2h-pyran-2-one derivatives
JPH0692381B2 (ja) * 1980-03-31 1994-11-16 三共株式会社 Ｍｂ−５３０ａ誘導体
JPS56142236A (en) 1980-04-08 1981-11-06 Sankyo Co Ltd Ml-236a and mb-530a derivative
MX7065E (es) * 1980-06-06 1987-04-10 Sankyo Co Un procedimiento microbiologico para preparar derivados de ml-236b
JPS5835144A (ja) * 1981-08-27 1983-03-01 Sankyo Co Ltd Ｍｂ−５３０ｂ誘導体およびその製造法
US4782084A (en) * 1987-06-29 1988-11-01 Merck & Co., Inc. HMG-COA reductase inhibitors
US4997848A (en) 1987-10-27 1991-03-05 Sankyo Company, Limited Octahydronaphthalene oxime derivatives for cholesterol synthesis inhibition
CA2062023A1 (en) * 1992-02-10 1993-08-11 Jagroop S. Dahiya Novel fungal strains and use thereof in antibiotic production
EP0629184A1 (en) * 1992-03-04 1994-12-21 Fujisawa Pharmaceutical Co., Ltd. TETRALIN DERIVATIVES AS HMG-CoA REDUCTASE INHIBITORS
ZA933359B (en) 1992-05-15 1993-12-08 Sankyo Co Octahydronaphthalene oxime derivatives for cholesterol biosynthesis inhibition, their preparation and use
HU210867B (en) * 1992-11-04 1995-10-30 Biogal Gyogyszergyar Method for extraction and purification of mevinolin from culture medium
US6812007B1 (en) * 1992-11-04 2004-11-02 Keri Vilmos Process for the isolation and purification of mevinolin
SI9300303A (en) * 1993-06-08 1994-12-31 Krka Tovarna Zdravil Process for isolation of hypolipemic effective substance
US5409820A (en) * 1993-08-06 1995-04-25 Apotex, Inc. Process for the production of lovastatin using Coniothyrium fuckelii
US6046022A (en) 1996-09-30 2000-04-04 Peking University Methods and compositions employing red rice fermentation products
US7238348B2 (en) 1996-09-30 2007-07-03 Beijing Peking University Wbl Corporation Ltd. Method of treatment of osteoporosis with compositions of red rice fermentation products
IL132822A0 (en) 1998-03-20 2001-03-19 Biogal Gyogyszergyar Metabolic controlled fermentation procedure for the manufacture of lovastatin hydroxy acid
IL151290A0 (en) 2000-02-24 2003-04-10 Biogal Pharmaceutical Co Ltd Method of purifying a fermentation broth
DE01913139T1 (de) 2000-03-03 2005-03-31 Plus Chemical S.A. Ein verfahren zur reinigung von lovastatin und simvastatin mit verringertem gehalt an dimeren verunreinigungen
KR20010095780A (ko) * 2000-04-12 2001-11-07 나가오카 마사시 배아 홍국
IN192861B (sv) 2000-06-30 2004-05-22 Ranbaxy Lab Ltd
ATE356554T1 (de) 2001-02-09 2007-04-15 Unilever Nv Nahrungsmittel enthaltend sojaprotein und statin
KR100379075B1 (en) 2002-03-07 2003-04-08 Jinis Biopharmaceuticals Co Method for producing low cholesterol animal food product and food product therefrom
KR20020093147A (ko) * 2002-05-30 2002-12-13 지니스생명공학 주식회사 성인병 예방 및 치료 보조제
KR100710500B1 (ko) 2005-05-18 2007-04-24 고려대학교 산학협력단 홍국균을 이용한 모나콜린 ｋ 생산방법
WO2010069593A1 (en) 2008-12-19 2010-06-24 Krka, D. D., Novo Mesto Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates
EP2327682A1 (en) 2009-10-29 2011-06-01 KRKA, D.D., Novo Mesto Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates
RO128803A0 (ro) 2012-10-12 2013-09-30 Ion Gigel Fulga Compoziţie pentru tratamentul sau prevenirea dislipidemiilor
CN110331151A (zh) * 2019-04-11 2019-10-15 北京工商大学 紫色红曲菌mokH基因过表达菌株的构建方法
CN111297938A (zh) * 2020-03-11 2020-06-19 北京康立生医药技术开发有限公司 一种辅助降血脂组合物中洛伐他汀的检测方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5612114B2 (sv) * 1974-06-07 1981-03-18
JPS55150898A (en) * 1979-05-11 1980-11-25 Sankyo Co Ltd Preparation of a new physiologically active substance mb-530b
AU535944B2 (en) * 1979-06-15 1984-04-12 Merck & Co., Inc. Hypocholestermic fermentation products from aspergillus

Also Published As

Publication number Publication date
NO800451L (no) 1980-08-21
DK73080A (da) 1980-08-21
GB2046737A (en) 1980-11-19
NL191540C (nl) 1995-09-04
BE881825A (fr) 1980-08-20
MX6314E (es) 1985-04-01
IE49743B1 (en) 1985-12-11
AU532626B2 (en) 1983-10-06
ATA92980A (de) 1983-07-15
FR2449685B1 (fr) 1985-06-28
DE3006216C2 (de) 1985-10-31
DK21889D0 (da) 1989-01-18
DE3006216A1 (de) 1980-09-04
ES8103171A1 (es) 1981-02-16
ES488796A0 (es) 1981-02-16
NO153974C (no) 1986-06-25
PL222120A1 (sv) 1980-10-20
SG6784G (en) 1985-02-08
DK149095C (da) 1986-06-16
JPS5925599B2 (ja) 1984-06-19
KR830002801B1 (ko) 1983-12-16
DE3051175C2 (sv) 1989-12-21
JPS55111790A (en) 1980-08-28
SU969702A1 (ru) 1982-10-30
FI66427C (fi) 1984-10-10
FR2449685A1 (fr) 1980-09-19
FI800506A (fi) 1980-08-21
AT373915B (de) 1984-03-12
CH645890A5 (de) 1984-10-31
NL8001041A (nl) 1980-08-22
KR830002030A (ko) 1983-05-21
GB2046737B (en) 1983-01-12
CA1129794A (en) 1982-08-17
NO153974B (no) 1986-03-17
IT1175260B (it) 1987-07-01
AU5567380A (en) 1980-08-28
IT8067262A0 (it) 1980-02-20
ZA80962B (en) 1981-03-25
DD154494A5 (de) 1982-03-24
SU1158048A3 (ru) 1985-05-23
IE800321L (en) 1980-08-20
NL191540B (nl) 1995-05-01
PL124304B1 (en) 1983-01-31
SE453301B (sv) 1988-01-25
FI66427B (fi) 1984-06-29
HU182069B (en) 1983-12-28
PH15145A (en) 1982-08-24
DK21889A (da) 1989-01-18
NZ192919A (en) 1984-07-06
DK149095B (da) 1986-01-20

Similar Documents

Publication Publication Date Title
SE8001339L (sv) Antihyperkolesteraemiskt medel, monakolin k och framstellning derav
Tamura et al. Ascochlorin, a new antibiotic, found by paper-disc agar-diffusion method. I isolation, biological and chemical properties of ascochlorin (studies on antiviral and antitumor antibiotics. I)
NO176766C (no) Fremgangsmåte for fremstilling av en forbindelse med anthelmintaktivitet
FI931680A (fi) Foerbaettrat foerfarande foer syntetisering av (4r-cis)-1,1-dimetyletyl-6-cyanometyl-2,2-dimetyl-1,3-dioxan-4-acetat
SE8001338L (sv) "monacolin k"-framstellning
DE69017946T2 (de) Zellwachstum hemmende makrozyklische Lactone namens Combretastatin D-2.
BR8600329A (pt) Composto de 1,3-tiazol,processo para a sua preparacao,composicao inseticida e processo para combater insetos
JPS5592387A (en) Antibiotic substance tm-531
JPS56128774A (en) New physiologically active substance ebelactone and its preparation
SE8100134L (sv) Terpenoider, forfaranden for framstellning av desamma och farmaceutiska kompositioner innehallande desamma
KR890014457A (ko) 신규 아족시 화합물 및 그의 제조방법
KR880000594A (ko) 세균생산물질 ufc-n11, 그의 제조방법 및 용도
SE7513671L (sv) Desacyl-pepsidin och sett att framstella densamma
SE7910626L (sv) Ny antibiotisk bn-183b-substans och forfarande for framstellning derav
FI810710L (fi) Oligoribocidderivat av homocitronsyra foerfarande foer framstaellning av dessa och anvaendningen av dessa foer foerhindrande av karies
GB2093347B (en) Immunostimulant material tf-2 from fusobacterium sp
KR890003734A (ko) 신규한 nf-1616-904의 피라진옥사이드 화합물 및 이를 함유하는 약학 조성물
SE7711542L (sv) Forfarande for framstellning av ett nytt antibiotikum c-15003 och hydrolysderivat derav
SE8005921L (sv) Nya foreningar med karcinostatisk och immunostimulerande aktivitet samt forfarande for framstellning derav
JPS5692786A (en) Cultivation of microorganism
JPS5651435A (en) Novel substance dc-44-a and dc-44-b, and their preparation
KR920002497A (ko) 스테롤 화합물
JPS54128575A (en) Novel pentalenonelactone compound and drugs comprising it as active constituent
JPS5492680A (en) Novel microorganism
JPS574975A (en) Phenazine derivative and its preparation

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8001339-4

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8001339-4

Format of ref document f/p: F